G D Ellison
Overview
Explore the profile of G D Ellison including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
48
Citations
442
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ellison G, Bryan K
Neurosci Lett
. 2009 Jul;
3(4):229-32.
PMID: 19604891
Rats were administered intraventricular injections of 6-hydroxydopamine (6-OHDA) and allowed to recover in either isolation cages or in an enriched, non-crowded rat colony environment. When tested 45 days after 6-OHDA,...
2.
Martinez Z, Oostwegel J, Geyer M, Ellison G, Swerdlow N
Neuropsychopharmacology
. 2000 Oct;
23(5):517-27.
PMID: 11027917
Both dopamine (DA) agonists and NMDA antagonists produce prepulse inhibition (PPI) deficits in rats that model PPI deficits in schizophrenia patients. While DA agonist effects on PPI are reversed by...
3.
Keys A, Ellison G
Pharmacol Toxicol
. 1999 Oct;
85(3):144-50.
PMID: 10522755
Animal models of clinical phenomena, such as stimulant-induced psychosis have focused primarily on persisting alterations that develop in brain after chronic stimulant administration. The present study utilized autoradiographic measures to...
4.
Martinez Z, Ellison G, Geyer M, Swerdlow N
Neuropsychopharmacology
. 1999 Jun;
21(1):28-39.
PMID: 10379517
Phencyclidine (PCP), a non-competitive NMDA antagonist with actions at multiple other central nervous system receptors, can cause both acute and lasting psychoses in humans, and has also been used in...
5.
Martinez Z, Ellison G, Geyer M, Swerdlow N
Psychopharmacology (Berl)
. 1999 Apr;
142(3):253-60.
PMID: 10208317
Deficient sensorimotor gating, as measured by a relative loss of prepulse inhibition (PPI) of the startle reflex, has been reported in schizophrenia patients and in rats treated acutely with dopamine...
6.
DeLorey T, Handforth A, Anagnostaras S, Homanics G, Minassian B, Asatourian A, et al.
J Neurosci
. 1998 Oct;
18(20):8505-14.
PMID: 9763493
Angelman syndrome (AS) is a severe neurodevelopmental disorder resulting from a deletion/mutation in maternal chromosome 15q11-13. The genes in 15q11-13 contributing to the full array of the clinical phenotype are...
7.
Ellison G, Keys A
Psychopharmacology (Berl)
. 1996 Aug;
126(3):271-4.
PMID: 8876027
Phencyclidine (PCP) can induce a model psychosis which has a number of similarities to dementias and schizophrenia. In some cases the psychosis persists for prolonged periods after drug discontinuation. N-Methyl-D-aspartate...
8.
Delfs J, Ellison G, Mercugliano M, Chesselet M
Exp Neurol
. 1995 Jun;
133(2):175-88.
PMID: 7544289
Long-term administration of neuroleptics can induce tardive dyskinesia in humans. Oral movements with the same distinctive form observed in humans with tardive dyskinesia are observed in rats treated with haloperidol...
9.
Lipton J, Olsen R, Ellison G
Brain Res
. 1995 Apr;
676(2):378-85.
PMID: 7614009
The effects of varied durations of cocaine (1, 3 or 5 days) on muscarinic (MSC) and benzodiazepine (BZD) binding sites in striatum and hippocampus were investigated using homogenate receptor binding....
10.
Delfs J, Yu L, Ellison G, Reisine T, Chesselet M
J Neurochem
. 1994 Aug;
63(2):777-80.
PMID: 8035203
The mRNA encoding mu-opioid receptors is expressed in neurons of the globus pallidus, a region of the basal ganglia that receives a dense enkephalinergic innervation from the striatum. The regulation...